GLP-1 drugs and PCOS: separating real benefits from TikTok hype

What did @branneisha actually say?

Honestly? Not much. The transcript here is "Did they have brains or not? Don't make me laugh. They were popular." That's it. There is no medical claim, no dosing advice, no PCOS explanation, and no GLP-1 commentary captured in these words. The caption tags Zempic and PCOS, but the spoken content does not deliver a fact-checkable health claim. This appears to be a reaction or commentary clip, likely referencing something off-screen or in a stitch, and without that context we are working with an incomplete picture.

That said, the hashtags tell us what world this video is playing in: semaglutide use for PCOS, a topic that is genuinely spreading fast on TikTok. So let's use this moment to interrogate what the broader conversation around GLP-1 drugs and PCOS actually gets right and wrong, because that community deserves a real answer.

Does the science back up GLP-1 use for PCOS?

There is real signal here, but the evidence is still maturing. GLP-1 receptor agonists like semaglutide and liraglutide have shown measurable benefit for women with PCOS in several clinical contexts, particularly around insulin resistance, weight reduction, and androgen levels. But "popular" does not equal "proven for every PCOS symptom."

A 2023 randomized trial by Elkind-Hirsch et al. published in the Journal of Clinical Endocrinology and Metabolism found that liraglutide combined with metformin improved menstrual regularity and reduced androgen excess in women with PCOS more than metformin alone. A separate 2022 systematic review by Tay et al. in Obesity Reviews confirmed that GLP-1 agonists reduced BMI and fasting insulin in PCOS populations, but noted heterogeneous outcomes on fertility and cycle regularity. The short version: these drugs can help with metabolic features of PCOS, but they are not a uniform fix, and they are not approved by the FDA specifically for PCOS treatment.

What did the video get wrong or right?

There is nothing specific to correct or credit in the spoken transcript, which is itself a problem. A video reaching 57,000 people under the hashtag "pcosproblems" and "zempic" carries implicit credibility weight regardless of whether the words are medically substantive. The vibe communicates endorsement even when the words do not.

What the broader TikTok PCOS-GLP-1 community frequently gets wrong is conflating weight loss from semaglutide with PCOS remission. Losing weight can improve hormonal profiles in PCOS, but the drug itself is not treating the underlying condition. It is also worth flagging that "Zempic" as a slang term sometimes refers to compounded semaglutide, which is categorically not the same product as FDA-approved Ozempic or Wegovy. Compounded versions have not undergone the same manufacturing standards, and assuming equivalency is a mistake with real safety implications.

What should you actually know?

If you have PCOS and you are considering a GLP-1 drug, here is what the evidence actually supports. First, GLP-1 agonists are not FDA-approved for PCOS, meaning any use in that context is off-label. That does not make it wrong, but it means you need a clinician who understands the nuance, not just a prescription written because it worked for someone on TikTok.

Second, insulin resistance is present in roughly 70 percent of women with PCOS according to Diamanti-Kandarakis and Dunaif (2012, Endocrine Reviews), and GLP-1 drugs address that mechanism directly. That is a legitimate reason your doctor might consider them. Third, if your primary goal is ovulation or fertility, the data is thinner. Talk to a reproductive endocrinologist, not a lifestyle influencer. Fourth, the social media framing of these drugs as a PCOS cure should make you skeptical every time you see it.

The bottom line on this video and this conversation

This specific video does not make a falsifiable claim, so it cannot be rated accurate or inaccurate on its face. But the ecosystem it participates in, PCOS plus semaglutide content on TikTok, is full of overstatement, anecdote presented as evidence, and the quiet implication that popular equals safe. Women with PCOS deserve better information than "they were popular." The drugs may genuinely help. The hype machine around them should still be questioned.